Devising a patent strategy to protect the IP of biologics in light of ambiguities, loopholes and pitfalls in the regulatory scheme.
Kaye Scholer LLP, 425 Park Avenue, New York, NY 10022-3598, USA.
Benjamin C
BC
Hsing
Sapna W
SW
Palla
D001688:Biological Products; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D018973:Intellectual Property; D010330:Patents as Topic / Q000331:legislation & jurisprudence
D001688:Biological Products